Clinical trial · Observational

Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.

Aprospective,Randomized,Comparative Clinical Trial of Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts.

NCT06973473CI-TRIAL-00089695not yet recruitingClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

To assess the clinical efficacy and safety of topical imiquimod 5% cream combined with cryotherapy versus either of theme alone for the treatment of common warts by clinical and dermoscopic assessments.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Warts	—	UNRESOLVED	—

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Design

Arms and outcomes

Arms (0)

[]

Primary outcomes (1)

measure
Complete clearance rate of common warts.
timeFrame
12 weeks
description
Assessment of complete warts clearance rate at 12weeks to evaluate the efficacy of combination therapy ( imiquimod5%cream+cryotherapy ) compared to topical imiquimod5%cream alone or cryotherapy alone in patients with common wart.

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years
Maximum age: 60 Years

Show eligibility criteria text

Inclusion Criteria:

* Patients with common warts diagnosed clinically and by dermoscopy.
* Patients older than 18years old.

Exclusion Criteria:

* Pregnancy and lactation.
* Immunosuppression or being under any kind of treatment causing
* absolute or relative immunosuppression.
* Patients with chronic systemic diseases.
* All cases of bleeding tendency or using anticoagulants.
* Concurrent use of systemic or topical treatments of warts in the last 4 weeks.

References

Publications (0)

Data not yet available

No reference posted for this study.